Dec 21, 2022 05:50 PM

China to Boost Supply of Pfizer’s Covid Pill as Demand Soars, Expert Says

What’s new: More Chinese residents will have access to U.S. pharma giant Pfizer Inc.’s Paxlovid as China looks to meet the high demand for the Covid drug, according to an infectious disease expert.

The country’s Covid playbook recommends three antiviral drugs, including Paxlovid, which will be “gradually made available at all medical institutions and at the community level,” said Wang Guiqiang, head of the infectious diseases department at Peking University First Hospital, during a press conference held by the State Council Tuesday.

You've accessed an article available only to subscribers
Share this article
Open WeChat and scan the QR code
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription